Pyrilutamide (KX-826) is discussed as an anti-androgen treatment for hair loss, with mixed user experiences. Some users report no results, while others find it mildly effective.
A 40-year-old user shared impressive hair regrowth results after three months using a topical spray containing minoxidil, finasteride, and ketoconazole, along with occasional dermarolling. The treatment, from the brand Hims, was effective despite initial skepticism, and the user credits the community for their support and information.
The user shares a 3-month hair loss treatment progress using finasteride, minoxidil, and ketoconazole shampoo. They plan to add a dermatologist pen to their routine for the next 3-6 months.
The conversation discusses interest in peptides for hair loss, specifically mentioning ahkCU and ghkCU. A user is considering adding ghkCU to their treatment regimen.
The conversation is about using oral finasteride and minoxidil for hair loss, with consideration of adding topical GHK-Cu for skin and hair benefits. The user seeks opinions on this combination.
The conversation discusses the potential of kintor pyrilutamide as a promising treatment for hair loss, with ongoing trials in various phases. There is skepticism due to delays in trial results, but the company is actively pursuing further trials.
A user warns against buying the Koreabeautics V2 microneedling pen, claiming it's marketed through fake success stories and is overpriced. Another user shares their experience, acknowledging the pen's quality but agreeing it's too expensive and reliant on frequent needle head replacements.
Ketoconazole shampoo can dry out hair, causing it to become frizzy and less manageable. Users suggest using conditioner, trying different shampoos, or reducing the frequency of ketoconazole use to mitigate these effects.
Clascoterone is promising for hair loss, showing 24.5% improvement in satisfaction compared to placebo. Users consider it an alternative to finasteride, with concerns about absorption and side effects.
SCUBE3 and GT20029 are potential treatments for hair loss, with SCUBE3 stimulating hair growth and GT20029 protecting against DHT. A combined approach using SCUBE3, finasteride or dutasteride, and later GT20029 could provide a comprehensive treatment for androgenetic alopecia.
The user reported noticeable hair improvement after four months using topical minoxidil, topical finasteride, microneedling, and ketoconazole shampoo. They plan to continue the regimen and are relieved by the progress.
User shared 7-month hair loss progress using finasteride, minoxidil, ketoconazole shampoo, and dermastamp. Hairline is stronger but still receding, hoping for more improvement.
Vitamin E and K deficiencies due to exocrine pancreatic insufficiency may affect hair growth. A scalp biopsy is recommended to check for autoimmune-related hair loss.
Use ketoconazole shampoo 1-2 times a week; daily use can cause dryness. Some users find daily use effective, but most recommend less frequent use with conditioner.
Use sulfate and paraben-free shampoos with biotin and collagen for daily use. Nizoral or Regenepure DR with ketoconazole can be used a few times a week for scalp health.
A breakthrough in hair follicle cultivation using induced pluripotent stem cells (iPSCs) has been achieved, producing large hair follicles suitable for transplantation. Clinical trials for this hair multiplication technology are planned in partnership with Yinguan Biotechnology.
PTD-DBM is a Korean-developed treatment for hair loss, with limited information available and some users testing it personally. A user purchased PTD-DBM for $115 and plans to test it on their temples, but its effectiveness and authenticity remain uncertain.
GHK-Cu is discussed as a potential hair loss treatment, with claims of promoting hair growth and possibly reversing gray hair, though strong clinical evidence is limited. The user also mentions using Minoxidil, red light therapy, and microneedling.
The conversation discusses the effectiveness of AMSbzs supplements in significantly increasing hair count, weight, and keratin content. The user questions why this treatment isn't more widely known despite its impressive results.
The conversation discusses the anticipation of clascoterone scalp treatment results for hair loss, with concerns about its availability and high cost. Users express hope for positive outcomes and affordable access.
The conversation discusses whether KX-826 is better than fluridil for hair loss treatment. A user claims fluridil is ineffective even when using 4 vials a day.
The user is overjoyed with hair regrowth progress using 1 mg finasteride, 2 ml liquid minoxidil, and ketoconazole shampoo. They applied minoxidil to the affected area without consulting a dermatologist and experienced some shedding for a few days.
The user experienced significant hair regrowth over four months using 1 mg finasteride, 2.5 minoxidil, and occasional ketoconazole. They reported no side effects from the treatments.
Injectable GHK-CU and BPC157 were discussed for hair loss, but users did not notice significant hair changes. BPC157 was noted to help with shoulder issues.
The user is pleased with the natural-looking results of their hair transplant, which used 4000 grafts at Woomchan Clinic in Seoul. The hairline appears very natural, and most people don't notice the transplant.
Corticosterone inhibits GAS6, affecting hair follicle stem-cell activity, with potential implications for stress-related hair loss. Ashwagandha and Vitamin K are suggested for reducing cortisol, but their effectiveness is debated.
A user shared a DIY recipe for a NutraKos-style amino acid mix as a cost-effective alternative to the expensive product, suggesting it as a complementary supplement for hair loss. Another user argued that proven treatments like finasteride and minoxidil are more reliable, questioning the efficacy of the amino acid mix.
The conversation discusses various hair loss treatments, including minoxidil, finasteride, dutasteride, pyrilutamide, alfatrodial, and nizoral, with a focus on the potential of new treatments like gt20029 and breezula. There is optimism about novel treatments that don't have systemic effects, although skepticism remains about the effectiveness of some new drugs.